» Articles » PMID: 39274423

Rubinstein-Taybi Syndrome Clinical Characteristics from the Perspective of Quality of Life and the Impact of the Disease on Family Functioning

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 Sep 14
PMID 39274423
Authors
Affiliations
Soon will be listed here.
Abstract

: Rubinstein-Taybi Syndrome (RSTS-OMIM, #180849) is a rare genetic disorder associated with distinctive clinical features, including a typical craniofacial appearance, global developmental delay, intellectual disability and broad, angular thumbs and fingers. The main aim of the study was to evaluate the health problems of children with RTST, their quality of life and the impact of the disease on family functioning. In addition, we investigate whether comorbidities, autistic behavior and eating problems affect the children's overall QOL. : A cross-sectional study was performed, including a total of 13 caregivers of children diagnosed with RSTS. A self-reported questionnaire [SRQ], medical records and the Pediatric Impact Module PedsQL 2.0, the Pediatric Quality of Life PedsQL 4.0 were used to obtain data on QOL and the impact of the disease on family functioning. : The overall QOL score for children with RSTS was x = 52.40; SD 13.01. The highest QOL was in emotional functioning (EF; x = 59.23; SD 18.69), while the lowest QOL was in physical functioning (PF; x = 48.56; SD 16.32) and social functioning (SF; x = 48.85; SD 18.84). There was a statistically significant negative correlation ( < 0.03; r = -2.01) between the age of the child and their QOL, indicating that older children had lower QOL scores. The mean overall rating for the impact of RSTS on family functioning was x = 50.00; SD 10.91. Caregivers reported the highest scores for cognitive functioning (CF; x = 64.23; SD 23.70) and family relationships (FR; x = 60.00; SD 17.17). The lowest scores were for daily activities (DA; x = 41.03; SD 17.17) and worry (W; x = 37.69; SD 18.55). : This study provides the first comprehensive exploration of the QOL of children with RSTS) and its impact on family functioning.

References
1.
Roelfsema J, White S, Ariyurek Y, Bartholdi D, Niedrist D, Papadia F . Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet. 2005; 76(4):572-80. PMC: 1199295. DOI: 10.1086/429130. View

2.
Miller R, Rubinstein J . Tumors in Rubinstein-Taybi syndrome. Am J Med Genet. 1995; 56(1):112-5. DOI: 10.1002/ajmg.1320560125. View

3.
Ogryzko V, Schiltz R, Russanova V, Howard B, Nakatani Y . The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 1996; 87(5):953-9. DOI: 10.1016/s0092-8674(00)82001-2. View

4.
GOODFELLOW A, Emmerson R, Calvert H . Rubinstein-Taybi syndrome and spontaneous keloids. Clin Exp Dermatol. 1980; 5(3):369-70. DOI: 10.1111/j.1365-2230.1980.tb01718.x. View

5.
Varni J, Burwinkle T, Seid M, Skarr D . The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003; 3(6):329-41. DOI: 10.1367/1539-4409(2003)003<0329:tpaapp>2.0.co;2. View